GeneralNewsBrief
<![CDATA[Molecular Imaging in Focus: Can the Newly FDA-Approved PET Agent Floretyrosine F18 Have an Impact for Glioma Im
Diagnostic Imagingtoday
<![CDATA[Molecular Imaging in Focus: Can the Newly FDA-Approved PET Agent Floretyrosine F18 Have an Impact for Glioma Imaging?]]>
Automated summary
RadPigeon summaries are original and for information only. They are not clinical advice.